⚕ GalenOps CRO console
← 701 (USA)

701-1148

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2013-08-23
Adverse events
10
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ACTINIC KERATOSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-12 (study day 174.0); relationship: NONE

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-25 (study day 3.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-25 (study day 3.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate CALCULUS URETHRAL — outcome: RECOVERED/RESOLVED; onset 2013-12-17 (study day 117.0); relationship: NONE

moderate assessed 2026-08-18

Moderate DEPRESSED MOOD — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-29 (study day -25.0); relationship: NONE

moderate assessed 2026-08-18

Moderate DYSPEPSIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-02; relationship: NONE

mild assessed 2026-08-18

Mild EPISTAXIS — outcome: RECOVERED/RESOLVED; onset 2014-01-03 (study day 134.0); relationship: NONE

moderate assessed 2026-08-18

Moderate FLANK PAIN — outcome: RECOVERED/RESOLVED; onset 2013-12-15 (study day 115.0); relationship: NONE

moderate assessed 2026-08-18

Moderate LOWER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-12 (study day 51.0); relationship: NONE

moderate assessed 2026-08-18

Moderate LOWER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2013-10-12 (study day 51.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.